✦ LIBER ✦

Vβ17 T-Cell Receptor Peptide Vaccine : Results of a Phase I Dose-Finding Study in Patients with Rheumatoid Arthritis

✍ Scribed by L. W. MORELAND; L. W. HECK Jr.; W. J. KOOPMAN; P. A. SAWAY; T. C. ADAMSON; Z. FRONEK; R. D. O'CONNOR; E. E. MORGAN; J. P. DIVELEY; N. M. CHIEFFO; T. D. FREEMAN; S. R. RICHIERI; D. J. CARLO; S. W. BROSTOFF

Book ID: 119872373
Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 144 KB
Volume: 756
Category: Article
ISSN: 0890-6564
DOI: 10.1111/j.1749-6632.1995.tb44514.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a phase I clinical trial of a

Results of a phase I clinical trial of a T-cell receptor peptide vaccine in patients with multiple sclerosis. I. Analysis of T-cell receptor utilization in CSF cell populations

✍ Darcy B Wilson; Anna B Golding; Richard A Smith; Tanya Dafashy; James Nelson; La 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 234 KB

Results of a phase I clinical trial of a

Results of a phase I clinical trial of a T-cell receptor vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utilization in CSF T-cell populations before and after vaccination with a TCRVβ6 CDR2 peptide

✍ Daniel P Gold; Richard A Smith; Anna B Golding; Elizabeth E Morgan; Tanya Dafash 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 199 KB

Atacicept in patients with rheumatoid ar

Atacicept in patients with rheumatoid arthritis: Results of a multicenter, phase ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose study

✍ P. P. Tak; R. M. Thurlings; C. Rossier; I. Nestorov; A. Dimic; V. Mircetic; M. R 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 2 views

A Phase I Dose-Finding Study of Silybin

A Phase I Dose-Finding Study of Silybin Phosphatidylcholine (Milk Thistle) in Patients With Advanced Hepatocellular Carcinoma

✍ Siegel, A. B.; Narayan, R.; Rodriguez, R.; Goyal, A.; Jacobson, DrPH, J. S.; Kel 📂 Article 📅 2013 🏛 SAGE Publications 🌐 English ⚖ 481 KB

Gemzar® (G) and epirubicin (E) in patien

Gemzar® (G) and epirubicin (E) in patients (pts) with metastatic breast cancer (MBC): Final results of a phase I dose finding study

✍ Fumoleau, P.; Viens, P.; Dieras, V.; Pujade-Lauraine, E.; Espie, M.; Kayitalire, 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 130 KB

S86 Results from the first phase I clini

S86 Results from the first phase I clinical study of the novel Ii-Key/HER-2(776–790) hybrid peptide vaccine in patients with prostate cancer

✍ S. Mpisias; T. Kalogeropoulos; E. Koutsiaris; A. Rempelakos; A. Konandreas; K. G 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 95 KB